CAESAREA, Israel, Aug. 11, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its second quarter 2017 results on Monday, August 14 and host a conference call at 9:00am ET. The Company will discuss its second quarter 2017 operating and financial results and its strategy and outlook for the remainder of 2017. The conference call will be hosted by Erez Raphael, Chief Executive Officer, and Zvi Ben-David, Chief Financial Officer. The live conference call can be accessed by dialing (888) 567-1603 or (862) 255-5347. Participants should ask for the DarioHealth Earnings Conference Call. The conference call will also be available via live webcast at: http://www.investorcalendar.com/event/19824

Conference Call Details:
Date: Monday, August 14, 2017
Time: 9:00AM ET
Dial-in Number: (888) 567-1603
International Dial-in Number: (862) 255-5347
Webcast: http://www.investorcalendar.com/event/19824

Participants are recommended to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through November 14, 2017. To listen to the replay, dial (877) 481-4010 (domestic) or (919) 882-2331 (international) and use replay ID 19824. The webcast replay will be available through November 14, 2017.

About DarioHealth Corp.

DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more information, visit http://mydario.investorroom.com/.

DarioHealth Corporate and Media Contact

Shmuel Herschberg
Marketing Director
shmuel@mydario.com
1-914-775-5548

DarioHealth Investor Relations Contact

Hayden IR
Stephen Hart
DRIO@HaydenIR.com
917-658-7878

SOURCE DarioHealth Corp.